Gwo Xi Stem Cell Applied Technology Co. , Statistics
Total Valuation
Gwo Xi Stem Cell Applied Technology Co. , has a market cap or net worth of TWD 3.09 billion. The enterprise value is 3.15 billion.
Market Cap | 3.09B |
Enterprise Value | 3.15B |
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024.
Earnings Date | Nov 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Gwo Xi Stem Cell Applied Technology Co. , has 95.95 million shares outstanding. The number of shares has increased by 6.48% in one year.
Shares Outstanding | 95.95M |
Shares Change (YoY) | +6.48% |
Shares Change (QoQ) | +5.15% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 0.02% |
Float | 95.95M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 20.06 |
PB Ratio | 4.45 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -30.40 |
EV / Sales | 20.94 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.52, with a Debt / Equity ratio of 55.55.
Current Ratio | 3.52 |
Quick Ratio | 3.38 |
Debt / Equity | 55.55 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -8.31 |
Financial Efficiency
Return on equity (ROE) is -17.66% and return on invested capital (ROIC) is -5.95%.
Return on Equity (ROE) | -17.66% |
Return on Assets (ROA) | -5.64% |
Return on Capital (ROIC) | -5.95% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.14 |
Inventory Turnover | 3.74 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.34% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -21.34% |
50-Day Moving Average | 34.08 |
200-Day Moving Average | 34.33 |
Relative Strength Index (RSI) | 43.46 |
Average Volume (20 Days) | 106,559 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Gwo Xi Stem Cell Applied Technology Co. , had revenue of TWD 150.50 million and -103.67 million in losses. Loss per share was -1.11.
Revenue | 150.50M |
Gross Profit | 106.32M |
Operating Income | -96.41M |
Pretax Income | -103.66M |
Net Income | -103.67M |
EBITDA | -44.35M |
EBIT | -96.41M |
Loss Per Share | -1.11 |
Balance Sheet
The company has 329.72 million in cash and 386.70 million in debt, giving a net cash position of -56.98 million or -0.59 per share.
Cash & Cash Equivalents | 329.72M |
Total Debt | 386.70M |
Net Cash | -56.98M |
Net Cash Per Share | -0.59 |
Equity (Book Value) | 696.10M |
Book Value Per Share | 7.25 |
Working Capital | 260.37M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 70.65%, with operating and profit margins of -64.06% and -68.89%.
Gross Margin | 70.65% |
Operating Margin | -64.06% |
Pretax Margin | -68.88% |
Profit Margin | -68.89% |
EBITDA Margin | -29.47% |
EBIT Margin | -64.06% |
FCF Margin | n/a |
Dividends & Yields
Gwo Xi Stem Cell Applied Technology Co. , does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -6.48% |
Shareholder Yield | -6.48% |
Earnings Yield | -3.43% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |